These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6329238)

  • 1. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ; Wells WG; Mirelman S
    Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ceftriaxone in serious bacterial infections.
    Epstein JS; Hasselquist SM; Simon GL
    Antimicrob Agents Chemother; 1982 Mar; 21(3):402-6. PubMed ID: 6285809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of ceftriaxone (R013-9904) in the treatment of septicemia caused by gram-negative bacilli].
    Naessens A; Pierard D; Roels P; Lauwers S
    Pathol Biol (Paris); 1983 May; 31(5):362-5. PubMed ID: 6312398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with ciprofloxacin in vitro and in vivo.
    Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
    Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy.
    Guggenbichler JP; Allerberger FJ; Dierich M
    Padiatr Padol; 1986; 21(4):335-42. PubMed ID: 3562044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiologic and clinical significance of cefotiam].
    Tauchnitz C; Ezold R; Bauer I; Berger HD; Buhl C; Goedecke A; Morawietz I
    Z Gesamte Inn Med; 1985 Mar; 40(5):143-8. PubMed ID: 3857792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
    Guibert J; Coppens H; Yvelin C
    Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of ceftriaxone in children].
    Terashima I; Uehara S; Toba T; Hayashi T; Hoshi M
    Jpn J Antibiot; 1984 Nov; 37(11):2021-6. PubMed ID: 6098698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation on ceftriaxone in the field of pediatrics].
    Haruta T; Kuroki S; Mayumi M; Matsuo H; Ohkura K; Kobayashi Y
    Jpn J Antibiot; 1984 Nov; 37(11):2141-51. PubMed ID: 6098707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of ceftriaxone in urinary and respiratory tract infections].
    Papierkowski A; Pietraszek-Mamcarz J; Kozłowska T; Górnicka G; Emeryk A
    Pol Tyg Lek; 1990 Apr 2-9; 45(14-15):300-2. PubMed ID: 2235713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.